Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant®

NCT05441618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-01-13

No results posted yet for this study

Summary

Retrospective, single center, single arm PMCF study on the performance and safety of Lyoplant® used for the replacement and extension of connective tissue structures in neurosurgery.

Conditions

  • Tumor, Cerebral Ventricle
  • Tumor, Cerebellar
  • Aneurysm Cerebral
  • Trauma, Brain

Interventions

DEVICE

Lyoplant®

replacement and extension of connective tissue structures in neurosurgery

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Philipp E Krauss, Dr. · Universitätsklinikum Augsburg AöR

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-02
Primary Completion
2024-12-19
Completion
2025-01-10

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05441618 on ClinicalTrials.gov